Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer

A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer

(2011) E. Casado et al.   CLINICAL CANCER RESEARCH

Significance of Acellular Mucin Pools in Rectal Carcinoma After Neoadjuvant Chemoradiotherapy

(2010) Jinru Shia et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immunohistochemical features of CD133 expression: Association with resistance to chemoradiotherapy in rectal cancer

(2010) Saigusa   ONCOLOGY REPORTS

Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy

(2009) Susumu Saigusa et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer

(2009) Qi Wang et al.   HISTOPATHOLOGY

The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer

(2009) David Horst et al.   JOURNAL OF PATHOLOGY

Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma

(2009) Dongho Choi et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas

(2008) Heike Immervoll et al.   BMC CANCER

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

(2008) D Horst et al.   BRITISH JOURNAL OF CANCER

Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study

(2008) Motohiro Kojima et al.   CANCER SCIENCE

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

(2008) L. Du et al.   CLINICAL CANCER RESEARCH

Cancer Stem Cell–Directed Therapies: Recent Data From the Laboratory and Clinic

(2008) Christopher Y Park et al.   MOLECULAR THERAPY